Patent ID: 8962013
Filing Date: 2015-02-24
Classification: A61K

Abstract:
1. A solid transdermal therapeutic system (TTS) with a UV absorber, said solid transdermal therapeutic system comprising a sequence of at least five layers; wherein said at least five layers comprise a backing layer ( wherein the adhesive layer ( wherein said UV absorber consists of 2,4-bis-([4-(2′-ethylhexyloxy)-2-hydroxy]phenyI)-6-(4-methoxyphenyl)-(1,3,5)-triazine as the sole UV absorber in the system, said UV absorber is present in a concentration of from 0.5 to 2.0% (m/m) in dissolved form in the adhesive laver and said UV absorber is also optionally present in the backing layer ( wherein said active pharmaceutical ingredient comprises at least one hormone; and wherein the solid transdermal therapeutic system is transparent.